Navigation Links
Hepatitis A Vaccine Best Bet to Treat Virus
Date:10/18/2007

CDC now recommends it instead of traditional immune globulin injection

THURSDAY, Oct. 18 (HealthDay News) -- Treating the liver disease hepatitis A with the hepatitis A vaccine is as effective as treating it with the more traditional injection of immune globulin, a new study found.

Based on these results, the U.S. Centers for Diseases Control and Prevention's Advisory Committee on Immunization Practices now recommends the vaccine as the preferred treatment for the hepatitis A virus, according to a report in the CDC's Oct. 19 issue of its Morbidity and Mortality Weekly Report.

"The primary finding of the study is that hepatitis A vaccine appears to work equally as well as immune globulin after exposure to the virus," said lead researcher John C. Victor, with the Program for Appropriate Technology in Health, in Seattle.

For the vaccine to be effective as a treatment, just like immune globulin, it must be given within two weeks of exposure to hepatitis A. "Any longer than that is too late," Victor said.

The vaccine appears to work, because hepatitis A has a 28-day incubation period, so the vaccine has time to build immunity before the virus takes hold, Victor said.

In the study, Victor's team randomly assigned 1,090 people from Almaty, Kazakhstan, who had been exposed to hepatitis A to either a dose of the hepatitis A vaccine or immune globulin. All the study participants were between 2 and 40 years old, according to a report on the study in an Oct. 18 early release from the New England Journal of Medicine.

The researchers found that of all the people in the trial, 25 who received the vaccine and 17 who received immune globulin later showed symptoms of hepatitis A. Victor's group concluded that treatment with the vaccine is as effective as immune globulin.

The advantage of the vaccine is that it's readily available and has fewer side effects than immune globulin, Victor said. "Anyone who has had immune globulin will tell you it's not always a very fun shot. It's like getting injected with corn syrup, and it tends to cause a lot of local reaction and pain at the site of the injection," he said.

Immune globulin also offers only six months of protection, while the vaccine -- especially if one gets a second dose -- will protect for life, Victor said. "To ensure long-term protection, you need that second shot," he said.

Because of these factors, the CDC is recommending the hepatitis A vaccine to fight infection in those aged 12 months to 40 years who have been exposed to the virus. The CDC also recommends that people traveling to areas where hepatitis A is endemic get one dose of the vaccine. This single shot should protect most healthy people, the agency said.

Hepatitis A infects the liver and is spread through close personal contact, Victor said, including household contacts especially with young children, sexual contact, and shared needles among drug users. It can also be transmitted by food handlers who don't practice good hygiene. "This is a fecal-oral transmitted virus," he said.

Symptoms -- typically more prevalent in adults than children -- include jaundice, fatigue, abdominal pain, loss of appetite, nausea, diarrhea and fever. There's no long-term infection -- once you've had hepatitis A, you can't get it again. About 15 percent of people infected with the virus will have prolonged or relapsing symptoms over a six-to-nine month period, according to the CDC.

Young children have been vaccinated against hepatitis A since 1995, Victor said. As a result, incidence of the disease has dropped dramatically. "There are less than 5,000 cases a year now in the United States, where we used to have tens of thousands," he said.

Dr. Carol J. Baker, an infectious disease specialist at Baylor College of Medicine, wrote an accompanying editorial in the journal. She thinks the vaccination recommendation is worthwhile, because the vaccine is a better choice than immune globulin.

"This is another success for hepatitis A vaccine," Baker said. "Now we know that the vaccine is equally protective after exposure to the virus as immune globulin."

Baker thinks this is important, because there's only one manufacturer of immune globulin in the United States. "If anything happens, then there is no way to treat people exposed to the virus," she said.

Also, the cost of the vaccine is similar to immune globulin, Baker said, adding that with two doses of vaccine, you are protected for life.

More information

For more on hepatitis A, visit the U.S. Centers for Disease Control and Prevention.



SOURCES: John C. Victor, Ph.D., M.P.H., Program for Appropriate Technology in Health, Seattle; Carol J. Baker, M.D., Baylor College of Medicine, Houston; Oct. 19, 2007, Morbidity and Mortality Weekly Report; Oct. 18, 2007, New England Journal of Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Tattoos may significantly increase risk of hepatitis C infection
2. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
3. New Treatment for Chronic Hepatitis B
4. Hepatitis A Cases On A Steady Increase In Canterbury
5. Vitamin B for Hepatitis
6. Hepatitis G May Boost HIV Survival
7. Cure for Hepatitis B
8. Hepatitis E virus made impotent
9. Sharing injection equipment spreads Hepatitis C
10. Lymphomas Link to Hepatitis C
11. Hepatitis shots is promising
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 , ... 1105 Media’s Live From program has been ... competition. Live From won in the Use of Social Media category. The Folio: ... undertaken by the media industry’s most innovative marketing professionals. , Conceived ...
(Date:12/7/2016)... ... 2016 , ... Gensuite is honored to be selected as ... Product Launch category. Gensuite’s entry on their EZ Scan feature detailed the tool’s ... Training Group is a professional event and training provider based in the United ...
(Date:12/7/2016)... ... ... Road To Restoration”: an informative and enlightening book for those who believe that ... “The Road To Restoration” is the creation of published author, Thomas Fitzhugh Sheets, seventy-one-year-old ... you could reach out for, and grab, on the old carousels. If you ...
(Date:12/7/2016)... ... ... Rides a Train” allows readers to tag along on a special shopping trip for ... creation of published author, Janet Morrison, who has been writing mostly poetry, essays, professional ... series is her first attempt at writing for children. Janet, Fred, and two cats ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg ... the International Probiotic Association’s Washington DC workshop on November 2nd. The conference was ... dialog regarding probiotic dietary supplement regulations. , Dr. Leyer spoke about two ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016 According to responses from ... than one-third (38%) of patients with non-small cell lung cancer ... factor receptor (EGFR) genetic mutation status. The findings of the ... LBA ID #6067 #P3.02b ) at the 2016 World ... . The survey results revealed an overall ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
(Date:12/7/2016)... Today, Stock-Callers.com presents four Biotech equities ... ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ), ProNAi ... (NASDAQ: AVXS ). From its peak in July ... reach a level equal to what it saw at the ... for the year, it has still out-performed other market sectors, ...
Breaking Medicine Technology: